India is going to introduce product patents, a move that will completely transform its pharmaceutical industry. The booming Indian pharmaceutical sector is to put so-called piracy aside and conform to a new patent regime designed to satisfy the Agreement on Trade-Related Aspects of Intellectual Property or TRIPS, one of the India's obligations as a member of the World Trade Organization (WTO). Among the most important aspects of TRIPS for pharmaceutical companies is the requirement that WTO members provide patent protection for a minimum of 20 years from the filing date of the application, for any invention, whether product or process.